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Abstract
To elucidate the effect of growth hormone (GH) on the insulin signal transduction pathway leading to the translocation of
glucose transporter-4 (GLUT4), we constructed Chinese hamster ovary cells that overexpressed GH receptor and GLUT4.
Treatment with GH triggered GLUT4 translocation, and this translocation was completely inhibited by wortmannin. GH-
induced GLUT4 translocation reached a maximum level after 30 min, and then gradually decreased and returned to the basal
level after 2 h. Tyrosine phosphorylation of JAK2 also became maximal after 30 min and then gradually decreased. In
contrast, GLUT4 translocation remained unchanged for 2 h after insulin treatment, and tyrosine phosphorylation of insulin
receptor substrate-1 (IRS-1) also remained constant for up to 2 h. Chronic GH treatment had almost no effect on insulin-
stimulated Akt kinase activation and GLUT4 translocation. These results suggest that GH and insulin translocate GLUT4 in
a similar manner, at least in part, and the difference in translocation depends on the difference in the tyrosine
phosphorylation of JAK2 and IRS-1. The anti-insulin action of GH after chronic GH treatment does not appear to be
mainly due to the inhibition of GLUT4 translocation. 0167-4889 / 98 / $ ^ see front matter ß 1998 Elsevier Science B.V. All
rights reserved.
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1. Introduction
A major consequence of the e¡ect of growth hor-
mone (GH) on glucose metabolism is an anti-insulin
action [1,2]. Patients with acromegaly often su¡er
from insulin-resistant diabetes [3]. However, it is
also known that GH mimics the action of insulin
in the short term [4,5]. These facts suggest that GH
modulates insulin action through the common path-
way of an intracellular signal transduction system. In
fact, recent studies have shown that GH activates
phosphatidylinositol 3-kinase (PI-3K) through the
phosphorylation of insulin receptor substrate-1
(IRS-1) [6,7]. This is also an important function of
insulin that leads to the activation of Akt kinase and
the translocation of glucose transporter-4 (GLUT4)
to the cell surface [8,9]. However, the mechanism of
the insulin-like e¡ect of GH on GLUT4 transloca-
tion and its characteristics compared to those of in-
sulin-mediated translocation have not been well char-
acterized. In addition, the existence of a common
pathway for insulin and GH raises the possibility
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that the anti-insulin e¡ect of GH might be mainly
caused by modulation of this pathway, which would
lead to the inhibition of GLUT4 translocation.
In this study, to elucidate these points, we con-
structed Chinese hamster ovary (CHO) cells that
overexpressed GH receptor and GLUT4 that was
sensitively detectable on the cell surface [10]. Using
this cell model, we compared the e¡ects of GH and
insulin on GLUT4 translocation. We also evaluated
whether GH has an anti-insulin e¡ect mainly
through the inhibition of GLUT4 translocation.
2. Materials and methods
2.1. Materials and cell preparation
Human growth hormone receptor (hGHR) cDNA
[11] was obtained from Genentech (South San Fran-
cisco, CA) and a mammalian expression vector
pCXN was a kind gift from Dr. J. Miyazaki (Uni-
versity of Osaka, Osaka) [12].
The parent cells used in this study were CHO-
GLUT4myc, a CHO cell line that overexpressed
GLUT4myc, which were constructed by inserting a
human c-Myc epitope (14 amino acids) into the ¢rst
ectodomain of GLUT4 [10]. They were co-trans-
fected with a human growth hormone receptor ex-
pression plasmid pCXN-hGHR, which was con-
structed by inserting hGHR cDNA into the
plasmid pCXN at a BamHI site, and a blasticidine
S deaminase expression plasmid pSV2-bsr. Candidate
clones were selected with blasticidine S hydrochloride
and positive clones that overexpressed hGHR were
estimated from the binding of 125I-GH (NEN, Wil-
mington, DE). A clone which overexpressed hGHR
was named CHO-GLUT4myc-hGHR and used for
the following experiments.
2.2. GLUT4 translocation
CHO-GLUT4myc-hGHR cells were grown over-
night in 24-well plates, and subcon£uent cells were
incubated in 1 ml of KRH bu¡er (136 mM NaCl, 4.7
mM KCl, 1.25 mM MgSO4, 1.25 mM CaCl2, 20 mM
HEPES pH 7.5, 2 mg/ml BSA) for 30 min at 37‡C.
They were then treated with the indicated concentra-
tions of each ligand at 37‡C for the indicated times.
The increased numbers of GLUT4myc in the surface
of plasma membrane were measured using anti-c-
Myc antibody and were regarded as GLUT4myc
translocation as previously described [10].
2.3. IRS-1 and JAK2 phosphorylation
Cells were treated with insulin or GH for the in-
dicated times and then lysed in lysis bu¡er. After
immunoprecipitation with anti-JAK2 antibody (Sei-
kagaku, Tokyo) or anti-IRS-1 antibody, samples
were separated in 7% SDS-PAGE gels and analyzed
with anti-phosphotyrosine antibody (PY20) and
HRP-conjugated anti-mouse IgG (Amersham, Buck-
inghamshire, UK). Anti-IRS-1 antibody was pre-
pared by immunizing a mouse with a peptide (RYIP-
GATMGTSPALTGDEAAC) of rat IRS-1.
2.4. Akt kinase assay
After treatment with the indicated reagents for 5
min, cells were lysed in Laemmli’s sample bu¡er. 10
Wg of cell lysate was analyzed with an anti-Akt anti-
body and an ECL (enhanced chemiluminescence)
system (Amersham) after being separated in 7%
SDS-PAGE gels. The anti-Akt antibody was pre-
pared by immunizing a rabbit with a C-terminal pep-
tide (SLELDQRTHFPQFSYSASIRE) of rat Akt2.
Akt kinase activation was decided by the conversion
of non-phosphorylated Akt (Akt) to phosphorylated
Akt (p-Akt) on the gel.
3. Results
3.1. E¡ect of short-term GH or insulin treatment
Translocation of GLUT4 was observed after the
cells were treated with GH for 15 min at a concen-
tration as low as 5 ng/ml. The maximum amount of
GH-induced translocation (approximately 50% of
that observed with 3U1036 M insulin) was observed
with 500 ng/ml GH. When the cells were pre-treated
with 3U1036 M wortmannin, which strongly inhibits
PI-3K, for 20 min, the e¡ects of both GH and insulin
on GLUT4 translocation were completely inhibited
(Fig. 1).
We compared the changes in GLUT4 transloca-
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tion induced by GH and insulin following a change
in the duration of incubation. GLUT4 translocation
induced by 500 ng/ml GH reached a maximum level
after 30 min of incubation, and then began to de-
cline. After 120 min of GH treatment, GLUT4 trans-
location returned to the basal level. In contrast,
GLUT4 translocation induced by treatment with
1037 M insulin remained relatively constant for up
to 120 min. The addition of GH did not a¡ect
GLUT4 translocation induced by insulin (Fig. 2).
The transducers of insulin actions, such as IRS-1,
2 and 3, are known to be rapidly phosphorylated
after insulin treatment [9,13,14]. During treatment
with GH or insulin, the changes in the tyrosine phos-
phorylation of either JAK2 or IRS-1 were examined.
The degree of tyrosine phosphorylation of JAK2
during GH treatment became maximal after 30
min, and then gradually decreased. That of IRS-1
Fig. 1. E¡ect of wortmannin treatment on GLUT4 transloca-
tion stimulated by GH or insulin. CHO cells were treated with
3U1036 M wortmannin for 20 min and then stimulated with
500 ng/ml GH or 3U1036 M insulin for 15 min. Each column
(bar) represents the mean (standard deviation) of GLUT4 trans-
location (n = 3). The vertical axis indicates the amount of
GLUT4-myc detected by anti-myc antibody on the cell surface.
Fig. 2. Time course of GLUT4 translocation after stimulation
with GH or insulin. CHO cells were stimulated with 500 ng/ml
GH or 1037 M insulin for up to 2 h and GLUT4 translocation
was followed. Bars represent the standard deviation (n = 3). The
tyrosine phosphorylation of JAK2 or IRS-1 induced by GH or
insulin was simultaneously examined in 7% SDS-PAGE gels us-
ing the anti-phosphotyrosine antibody (PY20) and HRP-conju-
gated anti-mouse IgG. The vertical axis indicates the amount of
GLUT4-myc detected by anti-myc antibody on the cell surface.
Fig. 3. Activation of Akt kinase and phosphorylation of IRS-1
by GH or insulin. (a) After treatment with or without 3U1036
M wortmannin for 20 min, cells were stimulated with 500
ng/ml GH or 3U1036 M insulin for 5 min, and they were lysed
in Laemmli’s sample bu¡er. 10 Wg of cell lysate was analyzed
with an anti-Akt antibody and an ECL system after separation
on 7% SDS-PAGE gels. Upper and lower bands indicate phos-
phorylated (p-Akt) and non-phosphorylated Akt (Akt), respec-
tively. Akt kinase activation was decided by the conversion of
Akt to p-Akt on the gel. (b) After treatment with or without
500 ng/ml GH for 6 h, cells were stimulated with 500 ng/ml
GH or 3U1036 M insulin for 5 min. Akt kinase activation was
decided on the gels. (c) After treatment with or without 500
ng/ml GH for 6 h, cells were stimulated with 3U1036 M insulin
for 5 min. The tyrosine phosphorylation of IRS-1 induced by
insulin was examined using the anti-phosphotyrosine antibody
(PY20) and an ECL system after separation on 7% SDS-PAGE
gels.
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during insulin treatment remained relatively constant
for up to 120 min (Fig. 2). The tyrosine phosphor-
ylation of IRS-1 during GH treatment was di⁄cult
to clearly detect in this cell line.
The results of Akt kinase activation after treat-
ment with 500 ng/ml GH or 3U1036 M insulin are
shown in Fig. 3a. GH activated Akt kinase, but this
activation was weak compared to that induced by
insulin. The addition of 500 ng/ml GH did not in£u-
ence insulin-induced Akt kinase activation. The acti-
vation of Akt kinase by either GH or insulin was
inhibited by 3U1036 M wortmannin.
3.2. E¡ect of long-term pretreatment with GH
After 6, 24 or 48 h of pretreatment with 500 ng/ml
GH, GLUT4 translocation stimulated by 500 ng/ml
GH or 1037 M insulin was examined. When cells
that did not overexpress GHR were examined, insu-
lin-induced GLUT4 translocation was not inhibited
at all. When cells that overexpressed GHR were ex-
amined, GH-induced GLUT4 translocation was
completely inhibited, suggesting that the cells were
resistant to GH. Under the same conditions, insu-
lin-induced GLUT4 translocation was not signi¢-
cantly inhibited (Fig. 4). Likewise, 6 h of preincuba-
tion with 500 ng/ml GH did not reduce insulin-
stimulated Akt kinase activity and IRS-1 phosphor-
ylation (Fig. 3b,c).
4. Discussion
The transient insulin-like action of GH has been
explained in terms of transient GLUT1 and GLUT4
translocation to the cell surface in adipose tissues
and other target tissues of insulin [5]. In our experi-
ment, we constructed a cell model of GH action to
analyze the mechanism of the e¡ect of GH on
GLUT4 translocation, which is the main target of
insulin for control of the blood glucose level. The
maximum level of GLUT4 translocation induced by
GH was approximately 50% of that induced by
3U1036 M insulin in our system, and the e¡ects of
both GH and insulin were completely inhibited by
wortmannin. The activation of PI-3K following ty-
rosine phosphorylation of IRS-1 by GH has been
reported in primary adipocytes and 3T3-F442A ¢-
broblasts, but GLUT4 translocation without PI-3K
and Akt kinase activation in 3T3L1 adipocytes was
also reported by another group [6,7,15]. Our results
suggest the presence of a GLUT4 translocation path-
way mediated by GH through the activation of PI-
3K and Akt kinase in CHO cells, which is essentially
the same pathway for the e¡ect of insulin on GLUT4
translocation. However, GH action for GLUT4
translocation may not be able to be explained only
by this Akt kinase-related pathway, because the ac-
tivation of Akt kinase by GH was very weak. The
duration of GLUT4 translocation clearly di¡ered be-
Fig. 4. GLUT4 translocation after chronic GH treatment. Cells were preincubated with 500 ng/ml GH for 6, 24 or 48 h, and GLUT4
translocation induced by 500 ng/ml GH or 1037 M insulin was examined. Solid and hatched columns indicate translocation induced
by GH and insulin, respectively. Bars indicate the standard deviation (n = 3). GLUT4 translocation after 6 h GH preincubation was
performed once. The vertical axis indicates the amount of GLUT4-myc detected by anti-myc antibody on the cell surface.
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tween GH and insulin. GLUT4 translocation stimu-
lated by GH did not continue for a long time, where-
as that stimulated by insulin continued for at least 2
h. This result explains a previous observation that
glucose transport in adipose tissue that had been
stimulated by GH declined within 2 h [5]. These ¢nd-
ings are also consistent with the di¡erence in the
duration of tyrosine phosphorylation of either
JAK2 or IRS-1 induced by GH or insulin, suggesting
that the di¡erence in tyrosine phosphorylation of the
¢rst intracellular signal transducer of the e¡ects of
either GH or insulin leads to the di¡erence in the
duration of their e¡ect on glucose transport [9,16].
Long-term pretreatment with GH causes insulin
resistance in insulin-targeted tissues within a few
hours both in vitro and in vivo [1,2,17]. In our ex-
periment, GLUT4 translocation stimulated by insu-
lin did not decline signi¢cantly when cells were re-
sistant to GH stimulation with regard to GLUT4
translocation. In addition, pretreatment with GH
did not inhibit the insulin-induced phosphorylation
of IRS-1 and activation of Akt kinase signi¢cantly.
A previous study demonstrated that chronic GH
treatment inhibited insulin-stimulated hexose trans-
port more sensitively in 3T3-F442A adipocytes, sug-
gesting that the inhibition of GLUT4 translocation
was the major origin of the anti-insulin e¡ect of GH
[2]. However, recent molecular studies have shown
that chronic GH treatment decreased GLUT1
mRNA and protein in both low-density microsomes
and plasma membrane of adipocytes, whereas there
was no decrease in GLUT4 mRNA and protein [18^
20]. Comparing these observations with our present
results, it is suggested that chronic GH treatment
does not alter GLUT4 translocation to the cell sur-
face signi¢cantly; GH may have multiple e¡ects on
the insulin-signaling pathway [19^21]. The e¡ects of
chronic GH treatment on other e¡ects of insulin that
can modify glucose metabolism, such as glycogen
synthesis, must be clari¢ed to determine the origin
of the anti-insulin e¡ect of GH.
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